234 related articles for article (PubMed ID: 23043544)
21. Hypoxic-preconditioning induces neuroprotection against hypoxia-ischemia in newborn piglet brain.
Ara J; Fekete S; Frank M; Golden JA; Pleasure D; Valencia I
Neurobiol Dis; 2011 Aug; 43(2):473-85. PubMed ID: 21554956
[TBL] [Abstract][Full Text] [Related]
22. LincRNA-p21 promotes mesenchymal stem cell migration capacity and survival through hypoxic preconditioning.
Meng SS; Xu XP; Chang W; Lu ZH; Huang LL; Xu JY; Liu L; Qiu HB; Yang Y; Guo FM
Stem Cell Res Ther; 2018 Oct; 9(1):280. PubMed ID: 30359325
[TBL] [Abstract][Full Text] [Related]
23. Hypoxia-induced stroke tolerance in the mouse is mediated by erythropoietin.
Prass K; Scharff A; Ruscher K; Löwl D; Muselmann C; Victorov I; Kapinya K; Dirnagl U; Meisel A
Stroke; 2003 Aug; 34(8):1981-6. PubMed ID: 12829864
[TBL] [Abstract][Full Text] [Related]
24. Deferroxamine preconditioning promotes long-lasting retinal ischemic tolerance.
Zhu Y; Zhang L; Gidday JM
J Ocul Pharmacol Ther; 2008 Dec; 24(6):527-35. PubMed ID: 19046123
[TBL] [Abstract][Full Text] [Related]
25. Low dose N, N-dimethylsphingosine is cardioprotective and activates cytosolic sphingosine kinase by a PKCepsilon dependent mechanism.
Jin ZQ; Karliner JS
Cardiovasc Res; 2006 Sep; 71(4):725-34. PubMed ID: 16831409
[TBL] [Abstract][Full Text] [Related]
26. The role of HIF in cobalt-induced ischemic tolerance.
Jones SM; Novak AE; Elliott JP
Neuroscience; 2013 Nov; 252():420-30. PubMed ID: 23916558
[TBL] [Abstract][Full Text] [Related]
27. CC chemokine ligand 2 and its receptor regulate mucosal production of IL-12 and TGF-beta in high dose oral tolerance.
DePaolo RW; Rollins BJ; Kuziel W; Karpus WJ
J Immunol; 2003 Oct; 171(7):3560-7. PubMed ID: 14500652
[TBL] [Abstract][Full Text] [Related]
28. Sphingosine Kinase 2 Inhibition and Blood Sphingosine 1-Phosphate Levels.
Kharel Y; Morris EA; Congdon MD; Thorpe SB; Tomsig JL; Santos WL; Lynch KR
J Pharmacol Exp Ther; 2015 Oct; 355(1):23-31. PubMed ID: 26243740
[TBL] [Abstract][Full Text] [Related]
29. Impairment of chemical hypoxia-induced sphingosine kinase-1 expression and activation in rheumatoid arthritis synovial fibroblasts: A signature of exhaustion?
Zhao C; Amiable N; Laflamme M; Marsolais D; Di Battista JA; Fernandes MJ; Bourgoin SG
Biochem Pharmacol; 2019 Jul; 165():249-262. PubMed ID: 30753812
[TBL] [Abstract][Full Text] [Related]
30. Hypoxia-independent mechanisms of HIF-1α expression in astrocytes after ischemic preconditioning.
Hirayama Y; Koizumi S
Glia; 2017 Mar; 65(3):523-530. PubMed ID: 28063215
[TBL] [Abstract][Full Text] [Related]
31. Hypoxia-inducible factor in brain.
Sharp FR; Bergeron M; Bernaudin M
Adv Exp Med Biol; 2001; 502():273-91. PubMed ID: 11950144
[TBL] [Abstract][Full Text] [Related]
32. Isoflurane mediates protection from renal ischemia-reperfusion injury via sphingosine kinase and sphingosine-1-phosphate-dependent pathways.
Kim M; Kim M; Kim N; D'Agati VD; Emala CW; Lee HT
Am J Physiol Renal Physiol; 2007 Dec; 293(6):F1827-35. PubMed ID: 17898040
[TBL] [Abstract][Full Text] [Related]
33. Role of hypoxia inducible factor-1α in remote limb ischemic preconditioning.
Kalakech H; Tamareille S; Pons S; Godin-Ribuot D; Carmeliet P; Furber A; Martin V; Berdeaux A; Ghaleh B; Prunier F
J Mol Cell Cardiol; 2013 Dec; 65():98-104. PubMed ID: 24140799
[TBL] [Abstract][Full Text] [Related]
34. Brain-specific knock-out of hypoxia-inducible factor-1alpha reduces rather than increases hypoxic-ischemic damage.
Helton R; Cui J; Scheel JR; Ellison JA; Ames C; Gibson C; Blouw B; Ouyang L; Dragatsis I; Zeitlin S; Johnson RS; Lipton SA; Barlow C
J Neurosci; 2005 Apr; 25(16):4099-107. PubMed ID: 15843612
[TBL] [Abstract][Full Text] [Related]
35. Divergent roles of sphingosine kinases in kidney ischemia-reperfusion injury.
Jo SK; Bajwa A; Ye H; Vergis AL; Awad AS; Kharel Y; Lynch KR; Okusa MD
Kidney Int; 2009 Jan; 75(2):167-75. PubMed ID: 18971925
[TBL] [Abstract][Full Text] [Related]
36. Sphingosine kinase 2 (Sphk2) regulates platelet biogenesis by providing intracellular sphingosine 1-phosphate (S1P).
Zhang L; Urtz N; Gaertner F; Legate KR; Petzold T; Lorenz M; Mazharian A; Watson SP; Massberg S
Blood; 2013 Aug; 122(5):791-802. PubMed ID: 23775711
[TBL] [Abstract][Full Text] [Related]
37. Anti-inflammatory effects of sphingosine kinase modulation in inflammatory arthritis.
Lai WQ; Irwan AW; Goh HH; Howe HS; Yu DT; Valle-Oñate R; McInnes IB; Melendez AJ; Leung BP
J Immunol; 2008 Dec; 181(11):8010-7. PubMed ID: 19017993
[TBL] [Abstract][Full Text] [Related]
38. Role of hypoxia-inducible factor-1 in hypoxia-induced ischemic tolerance in neonatal rat brain.
Bergeron M; Gidday JM; Yu AY; Semenza GL; Ferriero DM; Sharp FR
Ann Neurol; 2000 Sep; 48(3):285-96. PubMed ID: 10976634
[TBL] [Abstract][Full Text] [Related]
39. When the sphingosine kinase 1/sphingosine 1-phosphate pathway meets hypoxia signaling: new targets for cancer therapy.
Ader I; Malavaud B; Cuvillier O
Cancer Res; 2009 May; 69(9):3723-6. PubMed ID: 19383898
[TBL] [Abstract][Full Text] [Related]
40. Hypoxic preconditioning induces neuroprotective stanniocalcin-1 in brain via IL-6 signaling.
Westberg JA; Serlachius M; Lankila P; Penkowa M; Hidalgo J; Andersson LC
Stroke; 2007 Mar; 38(3):1025-30. PubMed ID: 17272771
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
